Donbaloğlu, Z. Et Al. 2022. Evaluation of the influence of the gonadotropin-releasing hormone agonist therapy on growth and body mass index in girls with idiopathic central precocious puberty.. ESPE 2022 , (Rome, Italy), 343.

Donbaloğlu, Z., Bedel, A., Barsal Çetiner, E., Singin, B., Aydın Behram, B., Ünver Tuhan, H., ... Parlak, M.(2022). Evaluation of the influence of the gonadotropin-releasing hormone agonist therapy on growth and body mass index in girls with idiopathic central precocious puberty. . ESPE 2022 (pp.343). Rome, Italy

Donbaloğlu, ZEYNEP Et Al. "Evaluation of the influence of the gonadotropin-releasing hormone agonist therapy on growth and body mass index in girls with idiopathic central precocious puberty.," ESPE 2022, Rome, Italy, 2022

Donbaloğlu, ZEYNEP Et Al. "Evaluation of the influence of the gonadotropin-releasing hormone agonist therapy on growth and body mass index in girls with idiopathic central precocious puberty.." ESPE 2022 , Rome, Italy, pp.343, 2022

Donbaloğlu, Z. Et Al. (2022) . "Evaluation of the influence of the gonadotropin-releasing hormone agonist therapy on growth and body mass index in girls with idiopathic central precocious puberty.." ESPE 2022 , Rome, Italy, p.343.

@conferencepaper{conferencepaper, author={ZEYNEP DONBALOĞLU Et Al. }, title={Evaluation of the influence of the gonadotropin-releasing hormone agonist therapy on growth and body mass index in girls with idiopathic central precocious puberty.}, congress name={ESPE 2022}, city={Rome}, country={Italy}, year={2022}, pages={343} }